首页> 外文期刊>Internal medicine. >Efficacy of Early Intravenous Immunoglobulin for Eosinophilic Granulomatosis with Polyangiitis with Drastically Progressive Neuropathy: A Synopsis of Two Cases
【24h】

Efficacy of Early Intravenous Immunoglobulin for Eosinophilic Granulomatosis with Polyangiitis with Drastically Progressive Neuropathy: A Synopsis of Two Cases

机译:早期静脉免疫球蛋白治疗嗜酸性肉芽肿伴多发性血管炎伴严重进行性神经病的疗效观察:2例

获取原文
           

摘要

Two women, 66-year-old and 63-year-old, were admitted for drastically progressive neuropathy, and diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA). Steroid pulse therapy failed to exert effect upon neuropathy, so we administered early intravenous immunoglobulin (IVIG) for fear of immobilization of neuropathy. This resulted in marked improvement in neuropathy without apparent side effects. Recent evidence suggests the efficacy of IVIG for steroid refractory neuropathy associated with EGPA, but has previously been administered during the chronic phase resulting in slow improvement. Our two successfully treated cases indicate the efficacy of early IVIG in preventing the immobilization of neuropathy, especially in progressive cases.
机译:两名分别为66岁和63岁的妇女因剧烈进行性神经病变而入院,并被诊断出患有嗜酸性肉芽肿并伴有多血管炎(EGPA)。类固醇脉冲疗法未能对神经病变产生作用,因此我们担心害怕神经病变的固定化,因此要尽早给予静脉注射免疫球蛋白(IVIG)。这导致神经病的明显改善而没有明显的副作用。最近的证据表明,IVIG对与EGPA相关的类固醇难治性神经病变具有疗效,但先前已在慢性期使用,导致改善缓慢。我们的两个成功治疗的病例表明了早期IVIG可以预防神经病变的固定,特别是在进行性病例中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号